Medicare Part D Rule Offers Modest Drug Price Savings, No Point-of-Sale Rebates
CMS Administrator Verma declined to suggest a timeframe for when such a policy redirecting negotiated drug rebates to offset cost sharing in Medicare Part D might be implemented.
You may also be interested in...
UnitedHealthcare Will Apply About 80% Of Rebates At Point-Of-Sale
Insurer offers additional details on upcoming rebate program, including how it will protect contract confidentiality, and which members might use it the most.
Trump's Drug Pricing Plans On Slow Walk? HHS To Solicit Comment On Policies
No big policy implementation expected to be announced during president's speech planned for next week. HHS will continue to gather feedback on various approaches to lowering drug pricing.
FDA's Gottlieb Applauds Drug Rebates At Point-Of-Sale
The US FDA commissioner called recent initiatives to get drug rebates to patients at point-of-sale "healthy" public policy, and suggested insurance premiums have been subsidized by sick patients, addressing CNBC's health care conference.